This is a demo store. No orders will be fulfilled.

FIDAS-5

    级别和纯度:
  • ≥98%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
F649416-1mg
1mg 期货 Stock Image
F649416-5mg
5mg 期货 Stock Image
F649416-10mg
10mg 期货 Stock Image
F649416-50mg
50mg 期货 Stock Image
F649416-100mg
100mg 期货 Stock Image
F649416-250mg
250mg 期货 Stock Image

基本描述

规格或纯度 ≥98%
英文名称 FIDAS-5
生化机理 FIDAS-5 是一种强效的蛋氨酸 S-腺苷转移酶 2A(MAT2A)口服活性抑制剂,IC50 为 2.1 μM。FIDAS-5 能有效竞争 S-腺苷蛋氨酸(SAM)与 MAT2A 的结合。FIDAS-5 具有抗癌活性。
储存温度 -20°C储存
运输条件 超低温冰袋运输
产品介绍


FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC 50 of 2.1 μM. FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-5 has anticancer activities

In Vitro

FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells. ?\nFIDAS-5 (3 μM) treatment inhibits the expression of c-Myc and cyclinD1 in LS174T CRC cells. And FIDAS-5 induces the expression of cell cycle inhibitor, p21 WAF1/CIP1. ?\nFIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: LS174T colorectal cancer (CRC) cells Concentration: 3 μM Incubation Time: 7 days Result: Significantly inhibited the proliferation of LS174T cells.

In Vivo

FIDAS-5 (20 mg/kg; oral gavage; daily; for two weeks; athymic nude mice) treatment significantly inhibits the growth of xenograft tumors, with minimal difference in body weight . ?\nMice are treated with FIDAS-5 (20 mg/kg) for 1 week. The liver SAM levels are significantly reduced . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: 16 athymic nude mice injected with HT29 CRC cells Dosage: 20 mg/kg Administration: Oral gavage; daily; for two weeks Result: Significantly inhibited the growth of xenograft tumors.

Form:Solid

IC50& Target:IC50: 2.1 μM (Methionine S-adenosyltransferase 2A (MAT2A))

纯度 ≥98%

关联靶点(人)

KCNH2 Tclin HERG (29587 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

分子类型 小分子
IIUPAC Name 4-[(E)-2-(2-chloro-6-fluorophenyl)ethenyl]-N-methylaniline
INCHI 1S/C15H13ClFN/c1-18-12-8-5-11(6-9-12)7-10-13-14(16)3-2-4-15(13)17/h2-10,18H,1H3/b10-7+
InChi Key KXVXICBOMOGFMH-JXMROGBWSA-N
Smiles CNC1=CC=C(C=C1)C=CC2=C(C=CC=C2Cl)F
Isomeric SMILES CNC1=CC=C(C=C1)/C=C/C2=C(C=CC=C2Cl)F
PubChem CID 57521314
分子量 261.72

化学和物理性质

溶解性 DMSO : 125 mg/mL (477.61 mM; Need ultrasonic)
分子量 261.720 g/mol
XLogP3 4.900
氢键供体数Hydrogen Bond Donor Count 1
氢键受体数Hydrogen Bond Acceptor Count 2
可旋转键计数Rotatable Bond Count 3
精确质量Exact Mass 261.072 Da
单同位素质量Monoisotopic Mass 261.072 Da
拓扑极表面积Topological Polar Surface Area 12.000 Ų
重原子数Heavy Atom Count 18
形式电荷Formal Charge 0
复杂度Complexity 274.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 0
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 1
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 1
共价键合单元计数Covalently-Bonded Unit Count 1

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

溶液计算器